NCT02185326View on ClinicalTrials.gov

Microflare Protocol in Poor Responders

PHASE4CompletedINTERVENTIONAL

Enrollment

145

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Female Infertility Due to Diminished Ovarian Reserve

Interventions

DRUG

Growth hormone (Norditropin, Novo nordisk)

Growth hormone (Norditropin, Novo nordisk) was administrated on day 6 of HMG stimulation daily in a dose of 2.5 mg S.C. till the day of hCG administration.

Trial Locations (1)

Unknown

Kasr el aini hospital, Cairo

All Listed Sponsors

lead

Woman's Health University Hospital, Egypt

OTHER

NCT02185326 - Microflare Protocol in Poor Responders | Biotech Hunter | Biotech Hunter